Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Insider Helen Louise Collins Sells 5,000 Shares of Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) insider Helen Louise Collins sold 5,000 shares of the firm’s stock in a transaction dated Friday, July 17th. The shares were sold at an average price of $52.67, for a total transaction of $263,350.00. Following the sale, the insider directly owned 25,000 shares in the company, valued at approximately $1,316,750. The trade was a 16.67% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Helen Louise Collins also recently made the following trade(s):

• On Wednesday, June 17th, Helen Louise Collins sold 5,000 shares of Bitwise MARA Option Income Strategy ETF stock. The stock was sold at an average price of $43.80, for a total transaction of $219,000.00.

Bitwise MARA Option Income Strategy ETF Stock Down 0.2%

IMRA opened at $14.49 on Wednesday. The firm has a 50 day moving average price of $16.52 and a 200-day moving average price of $15.48. Bitwise MARA Option Income Strategy ETF has a twelve month low of $11.99 and a twelve month high of $43.70. The stock has a market capitalization of $1.88 million, a price-to-earnings ratio of 289.80 and a beta of 2.74.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.